VEGF Receptor Subtypes KDR and FLT1 Show Different Sensitivities to Heparin and Placenta Growth Factor-Reference-Cited by-同舟云学术

VEGF Receptor Subtypes KDR and FLT1 Show Different Sensitivities to Heparin and Placenta Growth Factor

Published:1994-01 Issue:3 Volume:11 Page:187-195
ISSN:0897-7194
Container-title:Growth Factors
language:en
Short-container-title:Growth Factors

Author:

Terman Bruce I.,Khandke Lakshmi,Dougher-Vermazan Maureen,Maglione Domenico,Lassam Norman J.,Gospodarowicz Denis,Persico M. Graziella,Böhlen Peter,Eisinger Magdalena

Publisher

Informa UK Limited

Subject

Cell Biology,Clinical Biochemistry,Endocrinology

Link

http://www.tandfonline.com/doi/pdf/10.3109/08977199409046916

Reference33 articles.

1. The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor

2. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin.

3. Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins

4. Human Melanoma Cells but Not Normal Melanocytes Express Vascular Endothelial Growth Factor Receptors

5. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin–Avastin Complexes Show Enhanced VEGF Binding and Inhibition of VEGF-Mediated Cell Migration;International Journal of Translational Medicine;2021-08-10

2. Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A;Scientific Reports;2019-12

3. Trends and Challenges in Tumor Anti-Angiogenic Therapies;Cells;2019-09-18

4. Systemic Expression of Vascular Endothelial Growth Factor in Patients with Cerebral Cavernous Malformation Treated by Stereotactic Radiosurgery;Journal of Korean Neurosurgical Society;2016

5. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis;The FASEB Journal;2015-08